Accolade Inc
NASDAQ:ACCD
Accolade Inc
NASDAQ:ACCD
Price:
7.5 USD
-1.7%
Market Closed
Updated:
May 1, 2024
EV/GP
Enterprise Value to Gross Profit
Enterprise Value to Gross Profit
3.2
Current
5.5
Median
5.2
Industry
Lower
than median
Lower
than industry value
All Countries
| Market Cap | EV/GP | ||||
|---|---|---|---|---|---|
| US |
|
Accolade Inc
NASDAQ:ACCD
|
577.2m USD | 3.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
104.4B USD | 5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 4.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
72.9B USD | 2.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 6.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 5.8 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 5.3 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 6.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 4.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.3B USD | 5.3 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 128.5 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/GP
N/A
2-Years Forward
EV/GP
N/A
3-Years Forward
EV/GP
N/A
You don't have any saved screeners yet
